Drug Profile
SD 900
Alternative Names: Deuterium-substituted tofacitinib; SD-900Latest Information Update: 15 Jan 2015
Price :
$50
*
At a glance
- Originator Auspex Pharmaceuticals
- Class 2 ring heterocyclic compounds; Amides; Nitriles; Organic deuterium compounds; Piperidines; Pyrimidines; Pyrroles; Small molecules
- Mechanism of Action Immunosuppressants; Janus kinase 3 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 15 Jan 2015 Discontinued - Preclinical for Rheumatoid arthritis in USA (PO)
- 15 Nov 2012 Preclinical trials in Rheumatoid arthritis in USA (PO)